ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | -99.3% | 1,766 | -96.7% | 0.00% | – |
| Q4 2022 | $34,610 | -86.7% | 53,320 | -64.8% | 0.00% | -100.0% |
| Q3 2022 | $260,000 | +45.3% | 151,370 | +5.1% | 0.00% | +100.0% |
| Q2 2022 | $179,000 | -56.8% | 144,025 | -62.1% | 0.00% | -66.7% |
| Q4 2021 | $414,000 | +226.0% | 379,766 | +689.6% | 0.00% | +200.0% |
| Q2 2021 | $127,000 | +28.3% | 48,099 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $99,000 | +37.5% | 39,141 | +32.7% | 0.00% | -66.7% |
| Q1 2020 | $72,000 | – | 29,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |